These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 27591300)

  • 1. Epidemiology of chromosomal trisomies in the East of Ireland.
    McDonnell R; Monteith C; Kennelly M; Martin A; Betts D; Delany V; Lynch SA; Coulter-Smith S; Sheehan S; Mahony R
    J Public Health (Oxf); 2017 Dec; 39(4):e145-e151. PubMed ID: 27591300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of national prenatal screening on the time of diagnosis and outcome of pregnancies affected with common trisomies, a cohort study in the Northern Netherlands.
    Bouman K; Bakker MK; Birnie E; Ter Beek L; Bilardo CM; van Langen IM; de Walle HE
    BMC Pregnancy Childbirth; 2017 Jan; 17(1):4. PubMed ID: 28056858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical application of noninvasive prenatal testing for the detection of trisomies 21, 18, and 13: a hospital experience.
    Zhou Q; Pan L; Chen S; Chen F; Hwang R; Yang X; Wang W; Jiang J; Xu J; Huang H; Xu C
    Prenat Diagn; 2014 Nov; 34(11):1061-5. PubMed ID: 24899146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for trisomies by cell-free DNA testing of maternal blood: consequences of a failed result.
    Revello R; Sarno L; Ispas A; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Jun; 47(6):698-704. PubMed ID: 26743020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRIDENT-2: National Implementation of Genome-wide Non-invasive Prenatal Testing as a First-Tier Screening Test in the Netherlands.
    van der Meij KRM; Sistermans EA; Macville MVE; Stevens SJC; Bax CJ; Bekker MN; Bilardo CM; Boon EMJ; Boter M; Diderich KEM; de Die-Smulders CEM; Duin LK; Faas BHW; Feenstra I; Haak MC; Hoffer MJV; den Hollander NS; Hollink IHIM; Jehee FS; Knapen MFCM; Kooper AJA; van Langen IM; Lichtenbelt KD; Linskens IH; van Maarle MC; Oepkes D; Pieters MJ; Schuring-Blom GH; Sikkel E; Sikkema-Raddatz B; Smeets DFCM; Srebniak MI; Suijkerbuijk RF; Tan-Sindhunata GM; van der Ven AJEM; van Zelderen-Bhola SL; Henneman L; Galjaard RH; Van Opstal D; Weiss MM;
    Am J Hum Genet; 2019 Dec; 105(6):1091-1101. PubMed ID: 31708118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in fetal prevalence and outcome for trisomies 13 and 18: a population-based study over 23 years.
    Irving C; Richmond S; Wren C; Longster C; Embleton ND
    J Matern Fetal Neonatal Med; 2011 Jan; 24(1):137-41. PubMed ID: 20384468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the Z-score accuracy of noninvasive prenatal testing for fetal trisomies 13, 18 and 21 at a single center.
    Junhui W; Ru L; Qiuxia Y; Dan W; Xiuhong S; Yongling Z; Xiangyi J; Fatao L; Xuewei T; Guilan C; Fan J; Fucheng L; Fang F; Yan L; Lina Z; Cuixing Y; Jian L; Dongzhi L; Can L
    Prenat Diagn; 2021 May; 41(6):690-696. PubMed ID: 33480032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fetal fraction-based risk algorithm for non-invasive prenatal testing: screening for trisomies 13 and 18 and triploidy in women with low cell-free fetal DNA.
    McKanna T; Ryan A; Krinshpun S; Kareht S; Marchand K; Grabarits C; Ali M; McElheny A; Gardiner K; LeChien K; Hsu M; Saltzman D; Stosic M; Martin K; Benn P
    Ultrasound Obstet Gynecol; 2019 Jan; 53(1):73-79. PubMed ID: 30014528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-free DNA screening for trisomies 21, 18, and 13 in pregnancies at low and high risk for aneuploidy with genetic confirmation.
    Dar P; Jacobsson B; MacPherson C; Egbert M; Malone F; Wapner RJ; Roman AS; Khalil A; Faro R; Madankumar R; Edwards L; Haeri S; Silver R; Vohra N; Hyett J; Clunie G; Demko Z; Martin K; Rabinowitz M; Flood K; Carlsson Y; Doulaveris G; Malone C; Hallingstrom M; Klugman S; Clifton R; Kao C; Hakonarson H; Norton ME
    Am J Obstet Gynecol; 2022 Aug; 227(2):259.e1-259.e14. PubMed ID: 35085538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal age and the risk of fetal aneuploidy: A nationwide cohort study of more than 500 000 singleton pregnancies in Denmark from 2008 to 2017.
    Elmerdahl Frederiksen L; Ølgaard SM; Roos L; Petersen OB; Rode L; Hartwig T; Ekelund CK; ; Vogel I
    Acta Obstet Gynecol Scand; 2024 Feb; 103(2):351-359. PubMed ID: 37986093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The maternal age-specific live birth prevalence of trisomies 13 and 18 compared to trisomy 21 (Down syndrome).
    Savva GM; Walker K; Morris JK
    Prenat Diagn; 2010 Jan; 30(1):57-64. PubMed ID: 19911411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146,958 pregnancies.
    Zhang H; Gao Y; Jiang F; Fu M; Yuan Y; Guo Y; Zhu Z; Lin M; Liu Q; Tian Z; Zhang H; Chen F; Lau TK; Zhao L; Yi X; Yin Y; Wang W
    Ultrasound Obstet Gynecol; 2015 May; 45(5):530-8. PubMed ID: 25598039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twenty-year trends in the prevalence of Down syndrome and other trisomies in Europe: impact of maternal age and prenatal screening.
    Loane M; Morris JK; Addor MC; Arriola L; Budd J; Doray B; Garne E; Gatt M; Haeusler M; Khoshnood B; Klungsøyr Melve K; Latos-Bielenska A; McDonnell B; Mullaney C; O'Mahony M; Queisser-Wahrendorf A; Rankin J; Rissmann A; Rounding C; Salvador J; Tucker D; Wellesley D; Yevtushok L; Dolk H
    Eur J Hum Genet; 2013 Jan; 21(1):27-33. PubMed ID: 22713804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IONA test for first-trimester detection of trisomies 21, 18 and 13.
    Poon LC; Dumidrascu-Diris D; Francisco C; Fantasia I; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Feb; 47(2):184-7. PubMed ID: 26387684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive predictive value estimates for cell-free noninvasive prenatal screening from data of a large referral genetic diagnostic laboratory.
    Petersen AK; Cheung SW; Smith JL; Bi W; Ward PA; Peacock S; Braxton A; Van Den Veyver IB; Breman AM
    Am J Obstet Gynecol; 2017 Dec; 217(6):691.e1-691.e6. PubMed ID: 29032050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of five prenatal screening strategies for trisomies and other unbalanced chromosomal abnormalities: model-based analysis.
    Le Bras A; Salomon LJ; Bussières L; Malan V; Elie C; Mahallati H; Ville Y; Vekemans M; Durand-Zaleski I
    Ultrasound Obstet Gynecol; 2019 Nov; 54(5):596-603. PubMed ID: 31006923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [CLINICAL IMPLEMENTATION OF CELL-FREE DNA ANALYSIS IN MATERNAL BLOOD IN SCREENING FOR ANEUPLOIDIES IN SINGLETON PREGNANCIES].
    Chaveeva P; Yankova M; Stratieva V; Dimitrov I; Shterev A
    Akush Ginekol (Sofiia); 2016; 55(2):10-5. PubMed ID: 27509651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center.
    Lau TK; Cheung SW; Lo PS; Pursley AN; Chan MK; Jiang F; Zhang H; Wang W; Jong LF; Yuen OK; Chan HY; Chan WS; Choy KW
    Ultrasound Obstet Gynecol; 2014 Mar; 43(3):254-64. PubMed ID: 24339153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost and efficacy comparison of prenatal recall and reflex DNA screening for trisomy 21, 18 and 13.
    Bestwick JP; Wald NJ
    PLoS One; 2019; 14(7):e0220053. PubMed ID: 31344071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Replacing the combined test by cell-free DNA testing in screening for trisomies 21, 18 and 13: impact on the diagnosis of other chromosomal abnormalities.
    Syngelaki A; Pergament E; Homfray T; Akolekar R; Nicolaides KH
    Fetal Diagn Ther; 2014; 35(3):174-84. PubMed ID: 24525399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.